Current Concepts Review: Venous Thromboembolic Disease in Foot and Ankle Surgery

1. Abdollahi M Cushman M Rosendaal FR : Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb. Haemost. 89: 493–498, 2003

2. Ageno W Piantanida E Dentali F : Body mass index is associated with the development of the post-thrombotic syndrome. Thromb. Haemost. 89: 305–309, 2003

3. Agu O Hamilton G Baker D : Graduated compression stockings in the prevention of venous thromboembolism. Br. J. Surg. 86: 992–1004, 1999

4. Amaragiri SV Lees TA : Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 3: CD001484, 2000

5. Amstutz HC Friscia DA Dorey F Carney BT : Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement. J. Bone Joint Surg. 71A: 321–326, 1989

6. Appleby RD Olds RJ : The inherited basis of venous thrombosis. Pathology 29: 341–347, 1997

7. Arepally G Cines DB : Pathogenesis of heparin-induced thrombocytopenia and thrombosis. Autoimmun. Rev. 1: 125–132, 2002

8. Bauer KA Eriksson BI Lassen MR Turpie AG : Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N. Eng. J. Med. 345: 1305–1310, 2001

9. Bijsterveld NR Moon AH Boekhodlt SM : Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation 106: 2550–2554, 2002

10. Bijsterveld NR Vink R van Aken BE : Recombinant factor VIIa reverses the anticoagulant effect of the long acting pentasaccharide idraparinux in healthy volunteers. Br. J. Haematol. 124: 653–658, 2004

11. Buller H Davidson B Decousus H : Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: A randomized trial. Ann. Intern. Med. 140: 867–873, 2004

12. Caprini JA : Thrombosis risk assessment as a guide to quality patient care. Dis. Mon. 51: 70–78, 2005

13. Cirlincione AS Mendicino R Catanzariti R Grossman J : Low-molecular-weight heparin for deep vein thrombosis prophylaxis in foot and ankle surgery: a review. J. Foot Ankle Surg. 40: 96–100, 2001

14. Clagett GP Anderson FA Jr Geerts WH : Prevention of venous thromboembolism. Chest 114: 531S–560S, 1998

15. Colwell CW : Evidence-based guidelines for venous thromboembolism prophylaxis in orthopedic surgery. Orthopedics 30: 129–135, 2007

16. Colwell CW Jr. Spiro TE : Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty. Clin. Orthop. 319: 215–222, 1995

17. Comerota AJ Chouhan V Harada RN : The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann. Surg. 226: 306–314, 1997

18. Cushman M : Epidemiology and risk factors for venous thrombosis. Semin. Hematol. 44: 62–69, 2007

19. Dahl OE Caprini JA Colwell CW : Fatal vascular outcomes following major orthopaedic surgery. Thromb. Haemost. 93: 860–866, 2005

20. Delis KT Hunt N Strachan RK Nicolaides AN : Incidence, natural history, and risk factors of deep vein thrombosis in elective knee arthroscopy. Thromb. Haemost. 86: 817–821, 2001

21. DiGiovanni CW Restrepo A Gonzalez Della Valle AG : The safety and efficacy of intraoperative heparin in total hip arthroplasty. Clin. Orthop. 379: 178–185, 2000

22. DiMinno G Mannucci PM Tufano A : The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. J. Thromb. Haemost. 3: 1459–1466, 2005

23. Edmonds MJ Crichton TJ Runciman WB Pradhan M : Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J. Surg. 74: 1082–1097, 2004

24. Eisele R Kinzl L Koelsch T : Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombus. J. Bone Joint Surg. 89-A: 1050–1056, 2007

25. Eklöf B Maksimovic D Caprini JA Glase C : Air travel-related venous thromboembolism. Dis Mon. 51: 200–207, 2005

26. Eriksson BI Bauer KA Lassen MR Turpie ACG : Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip fracture surgery. N. Eng. J. Med. 345: 1298–1304, 2001

27. Fitzgerald RH Spiro TE Trowbridge AA : Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J. Bone Joint Surg. 83-A: 900–906, 2001

28. Freedman KB Brookenthal KR Fitzgerald RH Williams S Lonner JH : A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J. Bone Joint Surg. 82A: 929–938, 2000

29. Geerts WH Pineo GF Heit JA : Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (3 Suppl): 338S–400S, 2004

30. Girolami B Girolami A : Heparin-induced thrombocytopenia: a review. Semin. Thromb. Hemost. 32: 803–809, 2006

31. Goldhaber SZ : Medical progress: Pulmonary embolism. N. Eng. J. Med. 339: 93–104, 1998

32. Goldhaber SZ Tapson VF DVT FREE Steering Committee: A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am. J. Cardiol. 93: 259–262, 2004

33. Gonzalez R Haines K Nelson LG Gallagher SF Murr MM : Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 2: 30–35, 2006

34. Handoll HHG Farrar MJ McBirnie J : Heparin, low-molecular-weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 4: CD000305, 2002

35. Hanslow SS Grujic L Slater HK Chen D : Thromboembolic disease after foot and ankle surgery. Foot Ankle Int. 27: 693–695, 2006

36. Jorgensen PS Warming T Hansen K : Low-molecular-weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venographic controlled study. Thromb. Res. 105: 477–80, 2002

37. Kakkos SK Daskalopoulou SS Daskalopoulos ME Nicolaides AN Geroulakos G : Review of the value of graduated elastic compression stockings after deep vein thrombosis. Thromb. Haemost. 96: 441–445, 2006

38. Kearon C : Duration of venous thromboembolism prophylaxis after surgery. Chest 124 (6 Suppl): 386S–392S, 2003

39. Kearon C Julian JA Math M Newman TE Ginsberg JS : Noninvasive diagnosis of deep venous thrombosis. Ann. Int. Med. 128: 663–667, 1998

40. Kock HJ Schmit-Neuerburg KP Hanke J Rudofsky G Hirche H : Thrombo-prophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet 346: 459–461, 1995

41. Kolbach DN Sandbrink MW Hamulyak K Neumann HA Prins MH : Non-pharmaceutical measures for prevention of post-thrombotic syndrome, Cochrane Database Syst Rev 1: CD004174, 2004

42. Kucher N Tapson VF Goldhaber SZ DVT FREE Streeting Committee: Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb. Haemost. 93: 494–498, 2005

43. Kujath P Spannagel U Habscheid W : Incidence and prophylaxis of deep venous thrombosis in outpatients with injuries of the lower limb. Heamostasis 23 [Suppl 1]: 20–26, 1993

44. Lapidus LJ Rosfors S Ponzer S : Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture: a randomized, placebo-controlled study. J. Orthop. Trauma 21: 52–57, 2007

45. Lassen RM Borris LC Nakov RL : Use of low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N. Eng. J. Med. 347: 726–730, 2002

46. Lin PP Graham D Hann LE Boland PJ Healey JH : Deep venous thrombosis after orthopedic surgery in adult cancer patients. J. Surg. Oncol. 68: 41–47, 1998

47. Lindhoff-Last E Wenning B Gerdsen MS Bauersachs R Wagner R : Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia. Clin. Appl. Thromb. Hemost. 8: 347–352, 2002

48. Lonner JH Frank J McGuire K Lotke PA : Postthrombotic syndrome after asymptomatic deep vein thrombosis following total knee and hip arthroplasty. Am. J. Orthop. 35: 469–472, 2006

49. Lotke PA Callaghan JJ Dorr LD Engh GA : Prophylaxis for thromboembolic disease. J. Arthroplasty 20: 273–274, 2005

50. Lotke P Lonner J : The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty. Clin. Orthop. 452: 175–180, 2006

51. Malone PC Agutter PS : Review: The aetiology of deep venous thrombosis. QJM 99: 581–593, 2006

52. Menajovsky LB : Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am. J. Med. 118 [Suppl 8A]: 21S–30S, 2005

53. Mizel MS Temple HT Michelson JD : Thromboembolism after foot and ankle surgery. Clin. Orthop. 348: 180–185, 1998

54. Montgomery KD Potter HG Helfet DL : The detection and management of proximal deep vein thrombosis in patients with acute acetabular fractures: a follow up report. J. Orthop. Trauma 11: 330–336; 1997

National Institutes of Health: Prevention of venous thrombosis and pulmonary embolism. NIH Conensus Development. J. Am. Med. Assoc. 256: 744–749, 1986

56. Paiement GD Wessinger SJ Hughes R Harris WH : Routine use of adjusted low dose warfarin to prevent venous thromboembolism after total hip replacement. J. Bone Joint Surg. 75A: 893–898, 1993

57. Paeiment GD Wessinger SJ Waltman AC Harris WH : Surveillance of deep vein thrombosis in asymptomatic total hip replacement patients. Am. J. Surg. 155: 400–404, 1988

58. Palareti G Cosmi B Lignani C : Diagnosis of deep vein thrombosis. Semin. Thromb. Hemost. 32: 659–672, 2006

59. Piegsa K Guillebaud J : Oral contraceptives and the risk of DVT. Practitioner 240: 544–551, 1996

PERSIST investigators: A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation. J. Thromb. Haemost. 2: 47–53, 2004

Pulmonary Embolism Prevention (PEP) Trial: Prevention of pulmonary embolism and deep vein thrombosis with low-dose aspirin. Lancet 355: 1295–1302, 2000

62. Radl R Kastner N Aiger C : Venous thrombosis after hallux valgus surgery. J. Bone Joint Surg. 85-A: 1204–1208, 2003

63. Ramos J Perrotta C Badariotti G Berenstein G : Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. Cochrane Database Syst Rev 18: CD005259, April 18, 2007

64. Raskub GE Hull RD Pineo GF : Venous Thrombosis. In Lichtman MA Beutler E Kipps TJ . (eds.), Williams Hematology, 7th Edition. McGraw Hill Professional, New York, 2006

65. Salvati EA Gonzalez Della Valle A Westrich GH : The John Charnley Award. Heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin. Orthop. 441: 40–55, 2005

66. Salvati EA Sharrock NE Westrich G : Three decades of clinical, basic, and applied research on thromboembolic disease after THA. Clin. Orthop. 459: 246–254, 2007

67. Sculco TP Colwell CW Jr Pellegrini VD Jr Westrich GH Böttner F : Prophylaxis against venous thromboembolic disease in patients having a total hip or knee arthroplasty. J. Bone Joint Surg. 84A: 466–477, 2002

68. Solis G Saxby T : Incidence of DVT following surgery of the foot and ankle. Foot Ankle Int. 23: 411–414, 2002

69. Spannagel U Kujath P : Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster cast. Semin Thromb Hemost. 19 [Suppl 1]: 131–141, 1993

70. Syed FF Beeching NJ : Lower-limb deep-vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous drug use. Q.J.M. 98: 139–145, 2005

71. Turpie A Bauer KA Eriksson BI Lassen MR : Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopaedic surgery using different efficacy end points. Chest 126: 501–508, 2004

72. Turpie AGG Bauer KA Eriksson BI Lassen MR PENTATHLON 2000 Study Steering Committee: Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip replacement surgery: a randomized double blind trial. Lancet 359: 1721–1726, 2002

73. Turpie AGG Eriksson BI Bauer KA Lassen MR : Advances in therapeutics and diagnostics. Fondaparinux. J. Am. Acad. Orthop. Surg. 12: 371–375, 2004

74. Turpie AG Eriksson BI Lassen MR Bauer KA : A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. J. South. Orthop. Assoc. 11: 182–188, 2002

United States Department of Health and Human Resources: FDA Public Health Advisory: Reports of epidural or spinal hematomas with the concurrent use of low molecular weight heparin and spinal/epidural anesthesia or spinal puncture. Washington, DC, December 15, 1997

76. Urbankova J Quiroz R Kucher N Goldhaber SZ : Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in post-operative patients. Thromb. Haemost. 94: 1181–1185, 2005

77. Urbano F : Homan's sign in the diagnosis of deep venous thrombosis. Hospital Physician 37: 22–24, 2001

78. van Weert H Dolan G Wichers I : Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care. J. Fam. Pract. 55: 52–57, 2006

79. Virchow R : Cellular Pathology as Based Upon Physiological and Pathological Histology. London: Churchill; 1860

80. Wahlander K Larson G Lindahl TL : Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb. Haemost. 87: 580–585, 2002

81. Warkentin TE : Think of HIT. Hematology: Am. Soc. Hematol. Educ. Program, 2006: 408–414, 2006

82. Warkentin TE : Heparin-induced thrombocytopenia: a ten-year retrospective. Ann. Rev. Med. 50: 129–147, 1999

83. Warkentin TE Kelton J : A 14-year study of heparin-induced thrombocytopenia. Am. J. Med. 101: 502–507, 1996

84. Warkentin TE Roberts RS Hirsch J Kelton JG : An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch. Int. Med. 163: 2518–2524, 2003

85. Wein L Wein S Haas SJ Shaw J Krum H : Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167: 1476–1486, 2007

86. Weinmann EE Salzman EW : Deep-vein thrombosis. N. Engl. J. Med. 331: 1630–1641, 1994

87. Westrich GH Weksler BB Glueck CJ Blumenthal BF Salvati EA : Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J. Bone Joint Surg. 84-A: 2161–2167, 2002

88. Whang P Lieberman J : Low-molecular-weight heparin. J. Am. Acad. Orthop. Surg. 10: 299–302, 2002

89. Wille-Jorgensen P Jorgensen LN Crawford M : Asymptomatic post-operative deep vein thrombosis and the development of post-thrombotic syndrome. A systematic review and meta-analysis. Thromb. Haemost. 93: 236–241, 2005

90. Wolf JM DiGiovanni CW : A survey of orthopedics surgeons regarding DVT prophylaxis in foot and ankle trauma surgery. Orthopedics 27: 504–508, 2004